Tag: MDT

  • Highest Dividend Paying Stocks From Each Sector

    When looking at the highest dividend-paying stocks, investors tend to objectively judge solely on the basis of objective yield-related metrics and fundamentals. However, in many cases, investors show a preference for specific economic sectors, given the potential they find them to hold. For this reason, the specific sector the stock belongs to, also plays a critical role in their judgment of whether or not to add to their portfolio.

    Choosing between dividend stocks

    There hardly comes a better time to invest in stocks for those chasing dividends than in present circumstances. The raging bull market has come to a halt, leaving stocks of all classes trading significantly below their prices from barely a year ago. Although the S&P 500 has been recovering in the prior months, prices for many stocks still do not match up with robust fundamentals. The result is stocks trading at a discount, with inflated dividend yields. Accumulating these stocks in the present would result in a hefty dividend return, with a relatively small investment amount. In this article, we present the 7 highest dividend-paying stocks that belong to different sectors of the economy. This would allow sufficient diversification for those that seek to hold a safe and robust portfolio, delivering them dividend returns. It would also help point to which stock pays the best dividend in each sector.

    Energy Sector – Exxon Mobile

    The first name we present is the well-known oil and gas giant, Exxon Mobil Corp. (NYSE: XOM) which is a great stock for any dividend chaser to consider investing in. Dividend seekers would be pleased to know that Exxon Mobil has been rolling out dividends to its shareholders for an incredible 140 years. This means that throughout all the global stresses of the 20th and 21st century, XOM holders have without fail been earning a share of value through the company. At present, the company’s dividend yields at 3.78%, which stands above the sector median of 3.11%. This impressive yield enhances the attractiveness of the company to a significant degree.

    Shareholders can rely on the company’s robust business model. Its upside potential is further boosted by the deleveraging it has undertaken, capitalizing on the high cashflows earned during the high-margin inflationary period in the last year. Its strong balance sheet makes it capable to ride through broader headwinds in terms of supply chain complications, and geopolitical uncertainty.

    Healthcare Sector – Medtronic PLC

    Next up, we move onwards to the healthcare sector and take a look at the medical technology’s global leader, Metronic PLC (NYSE: MDT). The company, which holds a market cap of $125 billion dominates the markets of each segment it occupies at a global level. These segments include diabetes, cardiac & vascular, minimally invasive therapies, and restorative therapies.

    Given the strong market position this giant occupies, it has transformed itself into a free cash flow generator, by tapping into global demand for medical technology across hospitals. In its first quarter for 2022, the company reported a free cash flow figure of a whopping $5.2 billion. The result is an extremely strong dividend cushion. This means MDT is highly capable of sustaining and growing its dividends over time, as opposed to companies buried under overwhelming debt. It further holds a healthy 2.89% forward dividend yield, in comparison to the healthcare average of 1.34%.

    Industrials Sector – Genco Shipping & Trading Limited

    In the industrial sector, if we have to pick the highest dividend-paying stock, there is hardly a better pick than Genco Shipping & Trading Limited (NYSE: GNK). In the wake of bearish panic in the wider market, and broader macroeconomic headwinds, Genco has remained relatively stable throughout the year, falling by a mere 2% in the last 12 months. This comes despite the improving fundamentals that the company has been experiencing lately. In its most FY22Q2 results, Genco reports a 13.85% year-on-year revenue rise, and an exceptionally impressive 47% EPS jump.

    The GNK share price remaining unchanged in the wake of such impressive results indicates the significant discount it is presently trading at. As a result, the company’s forward dividend yield stands at an incredible 11%. Buying the stock now while its yield is in double-digit figures would be a great investment. To add to this dividend king’s strengths, the management has stated that it is confident that drydocking costs will be substantially lowered during Q3. They have also hinted at diverting some of this value towards a potential dividend hike.

    Financial Sector – Ares Management Corporation

    Next up, we turn to the highest dividend-paying stock, which belongs to the financial sector, and which holds extremely promising growth prospects. We are talking about none other than ARES Management Corporation (NYSE: ARES), which is a US-based alternative asset management and direct lending group. Given its unique business model, it remains largely resilient to macroeconomic headwinds, which makes it less cyclical than its peers in the financial sector.

    Given the stock’s 24% rise in the last month alone, it no longer is a value stock but remains extremely robust fundamentals and prospects. With rising interest rates, ARE’s forward prospects remain extremely high and enhance profit margins. The CAGR of ARE’s dividends in the last 5 years stands at an impressive 19.4%, owing to these interest rate trends. With its 75.5% payout, most of these benefits are diverted to shareholders in the form of dividends which yield 3.3%. Hardly does one come across such a high payout rate, while still benefiting from promising growth potential.

    Consumer Staples Sector – Flower Foods Inc.

    Next up, we turn to the highest dividend-paying stock, which belongs to US bakery product leader, Flower Foods Inc. (NYSE: FLO). Flower Foods has many things going for it, which would spark the interest of any dividend seeker. For one, the company has been enjoying tremendous growth, at a rapid pace, and is likely to do so well into the future. It is an all-weather company capable of surviving tough macroeconomic pressures, by passing over increased cost burdens to its customers. This price inelasticity makes the business highly resilient. Moreover, its large size and placement give it high levels of efficiency resulting from economies of scale. This gives it a significant competitive advantage over its regional peers.

    Flower Foods has consecutively upped its dividend payments to shareholders in the last 8 years. This shows its resilience given all the macroeconomic stresses of this period, including Covid-related lockdowns and restrictions. Its 3.2% dividend yield with a 67% payout makes it highly promising for those looking to strengthen their portfolio against inflationary or recessionary pressures.

    Communication Services Sector – Lumen Technologies Inc.

    Lumen Technologies Inc. (NYSE: LUMN) is a tech company that offers communications services throughout the United States and internationally. Owing to macroeconomic stresses and other headwinds facing the wider communication sector, Lumen too faced the adverse impacts of a business slowdown on its results. Its revenue had seen a 6.3% YoY decrease, as a result of these wider pressures.

    Despite these conditions, Lumen enjoys substantial cashflows which allow it to cover its dividend commitments with relative ease.  The management claims its cash flow position allows it to sustain dividends to shareholders well into the foreseeable future. Its low price and commitment to dividends have brought up its dividend yield to an incredible 9.4%. A yield of such a high magnitude is unlikely to remain this high, once the company overcomes present, short-term challenges.

    What is most impressive about LUMN is the immense growth potential it possesses, looking beyond short-term obstacles. The company is increasingly committing to quantum fiber operations, which resulted in 25,000 new subscribers in its most recent quarter. The company has sold off redundant assets to deliver net proceeds of $7 billion, which will be allocated to this high-growth domain. This is likely to further boost its dividend attractiveness.

    Consumer Discretionary Sector – Target Corporation

    We end our list of the highest dividend-paying stocks, with the undisputed dividend king itself, Target Corporation (NYSE: TGT). The stock has always been a favorite among dividend chasers, but two recent factors bring its attraction to unprecedented levels. The 17% price plummet in the last six months makes the stock’s dividend yield highly favorable. Secondly, a recent dividend increase announcement by management to $1.08 per share, shoots up its forward yield from 2.55% to an impressive 3.10%. This dividend increase amounts to a whopping 20%. The result is a present yield of 2.61%, which is the highest Target has ever offered.

    TGT is not only the highest dividend-paying stock but one that orders exceptional stability and growth prospects to one’s portfolio. It is extremely well-suited to survive through the worst of inflationary pressures, given its business model. Its large scale offers it a substantial competitive advantage over most players in the industry.

    Conclusion

    Every economic sector offers unique strengths that are most well-suited against a different set of circumstances. Dividend seekers tend to prefer stocks belonging to specific sectors, over those belonging to others. In this article, 7 different stocks have been highlighted, ranging from 7 different sectors. The list points out the highest dividend-paying stocks in each sector. Each of these is well suited for inclusion in any dividend chaser’s portfolio, given their strong fundamentals.

  • Measureable Data Token (MDT) – Will the Bearish Structure Stay?

    Measureable Data Token (MDT) – Will the Bearish Structure Stay?

    At the time of writing this article, MDT has a value of $0.08504 (22.57% increase today) with a trading volume of $118,144,452 with an increase of about871% over the past 24 hours. It has been of the top gainers today among the coins listed on Binance.

    MDT is listed on coinmarketcap in 519th place. It has negligible market dominance. MDT had created its all-time high around the price of $0.1788 in December 2021.  This month has been bullish for the price and we have seen an increase of about 40% in February. In January we saw a decrease of about 54%.

    The maximum supply of MDT is around 1B while the current circulating supply is around 673M coins.

    Technical Analysis – Measurable Data Token(MDT)

    If we talk about the technical portion of MDT coin, and starting from the daily time frame, the price on a macro scale is very bearish but that is just not too important. Although going with the trend is very favorable, like in this case, as macrostructure is bearish, it’s ideal to go with bears, but as price moves in waves, so one can also capitalize on the corrections which are bullish. Recently the price has tapped in a supply zone and has rejected quite much from that zone which shows that bears are interested in that level. The price did some inducement below so probably much liquidity has been taken which can drive the price downwards.

    MDT - 30M

    Moving lower which is a 4 Hour Time Frame, the price was quite momentous when it was pushing upside, but after bears got in, and did some consolidation, the last bullish wave was not much momentous. As it’s not too clear so let’s just move to 30 minute Time frame directly.

    In here the harmonic pattern ABCD has come to an end, and that end was within a supply zone, this makes the reversal strong. Talking about the structure, the price has done some Shift in the Market structure as it failed to create another high. Talking about invalidation the point of $0.09074 seems reasonable while the point of $0.7009 seems reasonable for the target

    Price Prediction – Measurable Data Token(MDT)

    According to wallet investor, MDT is one of the most successful investments in the market. According to their predictions, MDT is expected to reach a value of $0.0965 in a time span of one year. For a five-year plan, the price is expected to reach a value of $0.214.

  • The Three Top Healthcare Stocks to Buy in 2021

    The Three Top Healthcare Stocks to Buy in 2021

    The healthcare sector is a massive industry with a wide potential for investors.

    Healthcare is a basic necessity for people all over the world. Each year, we see new types of mysterious diseases that are often deadly. Such as the coronavirus is one of the broad examples of it. The global pandemic has caused more than 2.3 million deaths, and almost 107 million are facing the virus.

    Despite the health concerns, many of the health stocks made big gains. However, healthcare stocks as a whole underperformed the broader market, rising 11% compared to S&P 500 rose 15.9%. Still, the sentiment regarding healthcare stocks is high with the public health concerns. The vaccine is still in a frantic zone and many companies are still researching for more improvement.

    In that premise, healthcare is a big market and has massive potential. So, let’s have a look at the three top healthcare stocks to buy this year.

    Medtronic (MDT)

    Medtronic (MDT) is an American Irish-domiciled medical device corporation. The company generates most of its sales and profits from the US healthcare market. The healthcare firm with nearly $159 billion market value is a compelling stock for investors. Medtronic is among healthcare firms with safe, stable, and longer-term growth potential.

    Talking about Medtronic’s stability, the company is an exclusive member of the S&P dividend aristocrats list. This means that MDT is those dividend stocks that have raised their dividend payments for a consecutive 25 years long period or more. While MDT has an undisputed streak of over 43 years. 

    Medtronic has shown interest in investing in Compute Health Acquisition Corp., a blank-check company that is expected to go public—with an IPO of $750 million. The company has plans to buy almost 1.5 million units in the offering.

    Compute Health has plans to invest in the healthcare sector through the rising computing power and AI technology. This biotech healthcare is set to change the dynamics of the healthcare industry. So, Medtronic’s potential investment could be an effective one in the long-term.

    Vertex Pharmaceuticals (VRTX)

    Vertex Pharmaceuticals (VRTX) is one of the leading in the healthcare industry. The company’s primary focus remains on the development of drugs that treat the basic cause of cystic fibrosis (CF). CF is a rare genetic disease that causes lung problems and damages other organs, as well.

    The company’s most prominent drug, a 3-in-1 pill – Trikafta that obtain approval back in 2019, generated over $3.9 billion in sales for the very first year in 2020. Trikafta is anticipated to drive the company’s revenue for the next few years.

    Furthermore, Vertex’s management has indicated acquiring more assets to diversify its portfolio and accelerate its pipeline. VRTX shares are down and are expected to have an upward movement anytime soon. So, it’s one of the stocks to buy with potential upside.

    McKesson Corp. (MCK)

    McKesson Corp. (MCK) is a pharmaceutical and other healthcare products supplier and distributor. McKesson is more of a logistics firm, still, its involvement in the healthcare sector makes it a promising healthcare firm.

    The company recently reported third-quarter FY21 results which came on top with the rise in distribution services. The adjusted gross profit soared over 7% year-over-year, which was mostly driven by an incline in the distribution of COVID-19 tests. Moreover, McKesson’s work assembling ancillary supply kits for COVID-19 vaccines also played a key role in profit growth.

    The company distributed over 25 million vaccine doses of Moderna’s COVID-19 vaccine in January. The pharmaceutical distributor expects more contracts to be signed with the U.S. government for the distribution of more vaccines.   

    With this, the company has upgraded its full-year 2020 outlook and anticipates the adjusted earnings between $16.95 and $17.25 per share. So, McKesson Corp. (MCK) seems a suitable investment option with potential growth opportunity this year.

  • Top 15 Best Performing Medical Device Manufacture Companies Of 2020

    Top 15 Best Performing Medical Device Manufacture Companies Of 2020

    New medical innovations are emerging day by day and are playing a major role in the health care sector. Much of the credit for these new technological innovations go to the medical devices industry. Technological advancement is continuously changing the medical devices industry. The medical devices that provide and analyze data of patients within minutes are aiding the healthcare organizations to improve patients outcomes, lower costs, and enhance efficiency.

    2020 is the year of challenges and opportunities for many industries including the medical devices industry. The medical device industry is growing with fast speed and it doesn’t seem like it is going to be slowing down anytime soon. The growth in the medical devices industry has occurred because of increasing severe disease with the increasing population. These new diseases need new treatments that can reduce the symptoms in patients. The medical devices industry is important to patients for many reasons. Medical devices companies engaged in the innovations of new technologies that are helpful for patients with chronic diseases.

    Here are the top 15 leading players in the medical devices industry you should be holding right now:

    SmileDirectClub Inc. (NASDAQ: SDC)

    SmileDirectClub Inc. (NASDAQ: SDC) last closed at $11.27, in a 52-week range of $3.64 to $21.10. Analysts have a consensus price target of $10.08. SmileDirectClub Inc. (SDC) has partnered with Meredith Corporation (MDP) to introduce Telehealth Explained. Telehealth Explained is the new platform aimed to educate consumers about the many benefits of telehealth for physical, mental, and dental health.  SmileDirectClub Inc.’s market cap has remained high, hitting $4.66 billion at the time of writing.

    CHF Solutions Inc. (CHFS)

    CHF Solutions Inc. (CHFS) stock soar by 5.85% to $0.32. CHF Solutions Inc. (CHFS) has earlier disclosed that it has received 180-extension to meet the Nasdaq minimum bid price requirement. The company has now the time since February 24, 2021, to meet all the requirements.  CHFS has earlier hosted the interactive, physician-led webinar to discuss “Precision Medicine for the Treatment of Fluid Overload in Patients with Acute Heart Failure.” CHF Solutions has a 52-weeks low and high range of $0.28 and a low range of $2.92.

    Abbott Laboratories (NYSE: ABT)

    Abbott Laboratories (NYSE: ABT) stock soar by 2.89% to $105.81. The most recent rating by Goldman, on June 01, 2020, is at a Sell. Abbott Laboratories (ABT) has earlier disclosed that it has initiated the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company’s new Esprit™ BTK Everolimus-Eluting Resorbable Scaffold System.  ABT has a 52-weeks low and high range of $61.61 and $114.19, respectively. It has a market cap of $189.80 billion at the time of writing.

    Avinger Inc. (NASDAQ: AVGR)

    Avinger Inc. (NASDAQ: AVGR) Shares headed rising, higher as much as 3.70%. The most recent rating by Ladenburg Thalmann, on March 09, 2018, is at a Buy. Avinger Inc. (AVGR) has earlier disclosed that the underwriter of its earlier revealed underwritten public offering has practiced, in full, their option to purchase an additional 1,000,000 shares of the Company’s common stock at a price of $0.47 per share. Avinger Inc.’s market capitalization has remained high, hitting $36.67 million at the time of writing.

    InspireMD Inc. (AMEX: NSPR)

    InspireMD Inc. (AMEX: NSPR) fall -7.23% after losing more than -$0.02 on Wednesday. InspireMD Inc. has disclosed that it has received the FDA approval to proceed with a pivotal study of the CGuard Carotid Stent System, CARENET-III, for prevention of stroke in patients in the United States.  The FDA approval of Investigational Device Exemption (IDE) has been proved to be useful for the company as it is now able to conduct the trial to check the potential of CGuard EPS against carotid artery disease.

    BIOLASE Inc. (NASDAQ: BIOL)

    BIOLASE Inc. (NASDAQ: BIOL) last closed at $0.30, in a 52-week range of $0.21 to $1.16. BIOLASE Inc. (BIOL) has disclosed that Todd Norbe, President and CEO, and John Beaver, COO, and CFO, will be providing an overview of the Company, as well as recent progress and achievements at the Colliers & Co.  Institutional Investor Conference on Thursday, September 10, 2020. BIOLASE Inc. has a market capitalization of $26.66 million at the time of writing.

    Stryker Corporation (NYSE: SYK)

    Stryker Corporation (NYSE: SYK) stock soar by 2.66% to $205.41. The most recent rating by Barclays, on April 13, 2020, is at an Underweight. Stryker Corporation (SYK) has earlier revealed that it will take part in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference on Tuesday, September 15, 2020. This company’s market capitalization has remained high, hitting $77.31 billion at the time of writing.

    Livongo Health Inc. (NASDAQ: LVGO)

    Livongo Health Inc. (NASDAQ: LVGO) last closed at $128.03, in a 52-week range of $15.12 to $150.00. Analysts have a consensus price target of $130.41. Livongo Health Inc. (LVGO) disclosed that executives of Livongo Health and the executives from Teladoc Health will be participating in the following upcoming investor conferences. It had a trading volume of 1.72 million as compared to the average volume of 4.89 million.

    Boston Scientific Corporation (NYSE: BSX)

    Boston Scientific Corporation (NYSE: BSX) shares headed rising, higher as much as 1.49% after Boston Scientific Launches Vercise Genus™ DBS System In Europe. The most recent rating by SVB Leerink, on April 22, 2020, is at an Mkt perform. Boston Scientific Corporation (BSX) has a 52-weeks low and high range of $24.10 and $46.62, respectively. It has a market cap of $59.43 billion at the time of writing.

    Medtronic plc (NYSE: MDT)

    Medtronic plc (NYSE: MDT) rose 1.99% after gaining more than $2.08 on Wednesday. Medtronic Receives Breakthrough Device Designation from FDA, Begins Early Feasibility Study for Investigational Intrepid™ Transcatheter Valve System for the Treatment of Tricuspid Valve Regurgitation. Medtronic plc (MDT) has traded up 47.87% from its 52-weeks low and traded down -12.68% from its 52-weeks high.

    Ra Medical Systems Inc. (RMED)

    Ra Medical Systems Inc. (RMED) last closed at $0.25, in a 52-week range of $0.26 to $2.69. Ra Medical Systems to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 16. Ra Medical Systems Inc. (RMED) has traded down -2.46% from its 52-weeks low and traded down 90.57% from its 52-weeks high.

    Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI)

    Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) shares were trading up 12.80% at $0.41 at the time of writing on Wednesday. Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) share price went from a low point around $0.21 to briefly over $1.03 in the past 52 weeks, though shares have since pulled back to $0.41. HJLI market cap has remained high, hitting $16.12M at the time of writing.

    Nano-X Imaging Ltd. (NASDAQ: NNOX)

    Nano-X Imaging Ltd. (NASDAQ: NNOX) shares headed rising, higher as much as 7.76% after Nanox Signs Agreement With SPI Medical for the Deployment of 630 Nanox. Its stock has fluctuated between the 52-weeks low of $20.25 and a 52-weeks high range of $43.48. NNOX has moved up 117.33% and 1.24% from its 52-weeks low and high, respectively. Its market capitalization has remained high, hitting $2.08 billion.

    Edwards Lifesciences Corporation (NYSE: EW)

    Edwards Lifesciences Corporation (NYSE: EW) rose 3.26% after gaining more than $2.68 on Wednesday. Edwards Lifesciences Corporation (EW) stock has fluctuated between the 52-weeks low of $51.51 and a 52-weeks high range of $87.79. EW has moved up 64.72% from its 52-weeks low and moved down -3.36% from its 52-weeks high, respectively. Its market capitalization has remained high, hitting $54.00 billion.

    Wright Medical Group N.V. (NASDAQ: WMGI)

    Wright Medical Group N.V. (NASDAQ: WMGI) stock drop by -0.26% to $30.30. The most recent rating by Jefferies, on December 24, 2019, is at a Hold. Wright Medical Group N.V. (WMGI) has a 52-weeks low and high range of $19.04 and $30.66, respectively. It has a market capitalization of $2.92 billion.